RxDoctor Payments DataLook up a doctor →

Corinna Gamez

Psychiatry · San Francisco, CANPI 1245261791

Payments from drug & device makers

$2,030,719in general payments, 2019–2025

Across 389 payments — averaging $5220.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$578K
  • Otsuka Pharmaceutical Development & Commercialization, Inc.$426K
  • Acadia Pharmaceuticals Inc$210K
  • Sunovion Pharmaceuticals Inc.$189K
  • Janssen Research & Development, LLC$118K
  • Boehringer Ingelheim$72K
  • plus $438K from 16 others

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teva Pharmaceuticals USA, Inc.69$577,633
Otsuka Pharmaceutical Development & Commercialization, Inc.13$425,770
Acadia Pharmaceuticals Inc29$210,459
Sunovion Pharmaceuticals Inc.63$188,633
Janssen Research & Development, LLC39$117,976
Boehringer Ingelheim7$71,781
Corcept Therapeutics27$67,837
Tolmar, Inc.10$51,165
AbbVie10$49,218
Sage Therapeutics, LLC11$44,076
Mallinckrodt LLC11$40,941
GW Research Limited11$36,286
Avanir Pharmaceuticals, Inc.2$35,209
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)9$32,379
Roche TCRC, Inc.8$26,217
Janssen Global Services, LLC5$16,018
Boehringer Ingelheim International GmbH43$15,031
Sumitomo Pharma America, Inc.1$8,643
Vanda Pharmaceuticals Inc.3$8,595
Boehringer Ingelheim Pharma GmbH & Co.kg14$3,057
Pear Therapeutics (US), Inc.2$2,235
Novartis2$1,560

How this compares

$2,030,719 in reported general payments places this provider in the 95th percentile of 4,954 psychiatry providers in California.

See all psychiatry providers in California →

Other psychiatry in San Francisco

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →